Abstract

O-GlcNAcylation is a nutrient-driven post-translational modification known as a metabolic sensor that links metabolism to cellular function. Recent evidences indicate that the activation of O-GlcNAc pathway is a potential pro-survival pathway and that acute enhancement of this response is conducive to the survival of cells and tissues. 2-(4-Methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside (SalA-4g), is a salidroside analogue synthesized in our laboratory by chemical structure-modification, with a phenyl ring containing a para-methoxy group and a sugar ring consisting of N-acetylglucosamine. We have previously shown that SalA-4g elevates levels of protein O-GlcNAc and improves neuronal tolerance to ischemia. However, the specific target of SalA-4g regulating O-GlcNAcylation remains unknown. To address these questions, in this study, we have focused on mitochondrial network homeostasis mediated by O-GlcNAcylation in SalA-4g’s neuroprotection in primary cortical neurons under ischemic-like conditions. O-GlcNAc-modified mitochondria induced by SalA-4g demonstrated stronger neuroprotection under oxygen glucose deprivation and reoxygenation stress, including the improvement of mitochondrial homeostasis and bioenergy, and inhibition of mitochondrial apoptosis pathway. Blocking mitochondrial protein O-GlcNAcylation with OSMI-1 disrupted mitochondrial network homeostasis and antagonized the protective effects of SalA-4g. Collectively, these data demonstrate that mitochondrial homeostasis mediated by mitochondrial protein O-GlcNAcylation is critically involved in SalA-4g neuroprotection.

Highlights

  • The release of lactate dehydrogenase (LDH) induced by Oxygen-Glucose Deprivation/Reperfusion (OGD/R) was largely counteracted by SalA-4g (Figure 1B)

  • We found no significant change in protein O-GlcNAcylation on mitochondria in neurons under OGD/R stress, and, notably, there was a drastic increase in O-GlcNAc modification on mitochondria, especially in 40 μM and 200 μM SalA-4g groups9(Figof 19 ure 6D)

  • Considering that N-acetylglucosamine is a substrate for hexosamine biosynthetic pathway (HBP)-associated O-GlcNAc cycling, we reasoned that regulation of O-GlcNAc modification is the key pharmacological target of SalA-4g neuroprotection

Read more

Summary

Introduction

O-GlcNAcylation is a dynamic and reversible post-translational modification process, which occurs on serine or threonine residues of numerous nucleocytoplasmic proteins, including transcription factors, cytoskeletal proteins, and kinases [1]. The addition and removal of O-linked-β-N-acetylglucosamine (O-GlcNAc) are catalyzed by O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), respectively. OGT attaches O-GlcNAc moieties to specific substrate proteins using UDP-GlcNAc as the only sugar donor, which is synthesized from glucose through the hexosamine biosynthetic pathway (HBP). HBP is a sensor of cellular nutritional status. The recycling of O-GlcNAcylation rapidly occurs in response to cellular metabolic changes through the HBP [2,3,4]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call